CONMED (CNMD) Competitors $54.71 +1.33 (+2.49%) Closing price 03:59 PM EasternExtended Trading$54.76 +0.05 (+0.10%) As of 06:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CNMD vs. MMSI, GKOS, BLCO, IRTC, SLNO, INSP, TMDX, NVST, PRCT, and WRBYShould you be buying CONMED stock or one of its competitors? The main competitors of CONMED include Merit Medical Systems (MMSI), Glaukos (GKOS), Bausch + Lomb (BLCO), iRhythm Technologies (IRTC), Soleno Therapeutics (SLNO), Inspire Medical Systems (INSP), TransMedics Group (TMDX), Envista (NVST), PROCEPT BioRobotics (PRCT), and Warby Parker (WRBY). CONMED vs. Its Competitors Merit Medical Systems Glaukos Bausch + Lomb iRhythm Technologies Soleno Therapeutics Inspire Medical Systems TransMedics Group Envista PROCEPT BioRobotics Warby Parker CONMED (NYSE:CNMD) and Merit Medical Systems (NASDAQ:MMSI) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, risk, analyst recommendations, dividends, earnings, profitability, valuation and institutional ownership. Does the media favor CNMD or MMSI? In the previous week, Merit Medical Systems had 2 more articles in the media than CONMED. MarketBeat recorded 9 mentions for Merit Medical Systems and 7 mentions for CONMED. Merit Medical Systems' average media sentiment score of 0.84 beat CONMED's score of 0.78 indicating that Merit Medical Systems is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CONMED 3 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Merit Medical Systems 3 Very Positive mention(s) 4 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has preferable valuation and earnings, CNMD or MMSI? CONMED has higher earnings, but lower revenue than Merit Medical Systems. CONMED is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCONMED$1.31B1.30$132.42M$3.5315.50Merit Medical Systems$1.36B3.74$120.36M$1.9743.44 Which has more risk & volatility, CNMD or MMSI? CONMED has a beta of 1.17, suggesting that its share price is 17% more volatile than the S&P 500. Comparatively, Merit Medical Systems has a beta of 0.66, suggesting that its share price is 34% less volatile than the S&P 500. Is CNMD or MMSI more profitable? Merit Medical Systems' return on equity of 15.07% beat CONMED's return on equity.Company Net Margins Return on Equity Return on Assets CONMED8.31% 14.43% 6.05% Merit Medical Systems 8.31%15.07%8.60% Do analysts rate CNMD or MMSI? CONMED currently has a consensus target price of $59.80, indicating a potential upside of 9.30%. Merit Medical Systems has a consensus target price of $107.00, indicating a potential upside of 25.03%. Given Merit Medical Systems' stronger consensus rating and higher possible upside, analysts clearly believe Merit Medical Systems is more favorable than CONMED.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CONMED 0 Sell rating(s) 4 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.20Merit Medical Systems 0 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.89 Do insiders and institutionals believe in CNMD or MMSI? 99.7% of Merit Medical Systems shares are owned by institutional investors. 3.1% of CONMED shares are owned by company insiders. Comparatively, 3.2% of Merit Medical Systems shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. SummaryMerit Medical Systems beats CONMED on 12 of the 15 factors compared between the two stocks. Get CONMED News Delivered to You Automatically Sign up to receive the latest news and ratings for CNMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CNMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CNMD vs. The Competition Export to ExcelMetricCONMEDMED/DENTAL IndustryMedical SectorNYSE ExchangeMarket Cap$1.65B$14.89B$5.44B$20.70BDividend Yield1.50%1.54%4.61%3.67%P/E Ratio15.5017.8929.7528.40Price / Sales1.302.46449.4856.10Price / Cash7.9516.2336.4223.21Price / Book1.693.768.184.33Net Income$132.42M$430.42M$3.26B$996.14M7 Day Performance4.71%4.53%1.15%1.93%1 Month Performance4.23%-0.19%2.82%-0.54%1 Year Performance-19.33%15.68%28.41%14.79% CONMED Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CNMDCONMED3.9726 of 5 stars$54.71+2.5%$59.80+9.3%-19.9%$1.65B$1.31B15.503,900Dividend AnnouncementMMSIMerit Medical Systems4.5115 of 5 stars$84.46-0.3%$109.11+29.2%-3.4%$4.99B$1.39B41.407,400GKOSGlaukos4.0059 of 5 stars$94.80+0.5%$134.67+42.1%-24.1%$5.42B$383.48M-40.00780BLCOBausch + Lomb2.9553 of 5 stars$14.47+1.0%$15.45+6.8%-10.0%$5.12B$4.79B-14.0513,500IRTCiRhythm Technologies1.9477 of 5 stars$137.11+2.2%$137.30+0.1%+135.0%$4.38B$618.59M-43.672,000Insider TradeSLNOSoleno Therapeutics4.5698 of 5 stars$85.25-1.4%$108.70+27.5%+79.0%$4.30BN/A-18.4530News CoveragePositive NewsEarnings ReportAnalyst ForecastINSPInspire Medical Systems4.6241 of 5 stars$130.72+1.4%$208.55+59.5%-59.1%$3.86B$840.11M60.241,246Trending NewsEarnings ReportAnalyst ForecastAnalyst RevisionTMDXTransMedics Group2.4559 of 5 stars$105.24-2.7%$129.88+23.4%-20.4%$3.56B$441.54M77.38210NVSTEnvista3.4785 of 5 stars$20.73-0.3%$20.23-2.4%+31.2%$3.51B$2.51B-3.1712,300PRCTPROCEPT BioRobotics3.375 of 5 stars$54.08-2.9%$84.13+55.6%-34.1%$2.99B$224.50M-31.81430Trending NewsEarnings ReportAnalyst ForecastWRBYWarby Parker1.9939 of 5 stars$24.10-1.2%$22.88-5.1%+67.2%$2.52B$771.32M-200.833,780Trending NewsAnalyst ForecastAnalyst RevisionGap Up Related Companies and Tools Related Companies MMSI Competitors GKOS Competitors BLCO Competitors IRTC Competitors SLNO Competitors INSP Competitors TMDX Competitors NVST Competitors PRCT Competitors WRBY Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:CNMD) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredShocked one of my clients with thisTrump Schedules Controversial 'Market Reset' for September 30 Behind closed doors, the White House has orde...Altimetry | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredNVIDIA's Worst Nightmare?$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | Sponsored#1 Pre-IPO Opportunity For 2025 [Take Action Now!]James Altucher has scored 37X and even 60X returns on past pre-IPO deals. But now he says a much bigger opport...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CONMED Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share CONMED With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
